Nalân Utku

Title: Innovations by Nalân Utku in Immune Modulation

Introduction

Nalân Utku is a prominent inventor based in Dortmund, Germany. He has made significant contributions to the field of immunology through his innovative research and patented inventions. With a total of 2 patents, Utku's work focuses on the modulation of immune responses, which has important implications for treating various immune diseases.

Latest Patents

Utku's latest patents include groundbreaking developments in the area of immune modulation. One of his notable inventions is a set of peptides capable of modulating the function of TIRC7. These peptides are designed to inhibit the proliferation of peripheral blood mononuclear cells (PBMCs) derived from the third extracellular domain of the T-cell immune response cDNA7 (TIRC7) costimulatory molecule. The compositions comprising these peptides are intended for use in the treatment of immune diseases.

Another significant patent involves a method of detecting early immune activation. This method focuses on diagnosing early immune activation by detecting T-cell immune response cDNA 7 (TIRC7). Specifically, TIRC7 serves as an early biomarker for the detection of transplant rejection through non-invasive diagnostic methods. This innovative approach replaces traditional biopsy interventions with a simpler diagnostic method for monitoring patients after transplantation. Additionally, kits for use in these diagnostic methods are also provided.

Career Highlights

Nalân Utku is currently associated with Cellact Pharma GmbH, where he continues to advance his research in immunology. His work at the company emphasizes the development of novel therapeutic strategies aimed at improving patient outcomes in immune-related conditions.

Conclusion

Nalân Utku's contributions to the field of immunology through his patents and research are paving the way for innovative treatments for immune diseases. His work exemplifies the importance of scientific innovation in addressing complex health challenges.